For instance, antibodies which block the vessel de-stabilizing Tie2 receptor ligand Ang2 or dual anti-VEGF/Ang2 antibodies effectively increase endothelial cell integrity in mouse models of mammary carcinoma and pancreatic neuroendocrine tumors [24,25]. Here, VEGFA is linked to breast carcinoma.